Pieter J. Vlaar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Pieter J. Vlaar has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Felix Zijlstra
7 shared publicationsTone Svilaas
Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
6 shared publications- Albert J. H. Suurmeijer
Department of Pathology University Medical Center Groningen, University of Groningen Groningen The Netherlands
3 shared publications - Felix Zijlstra
Department of Cardiology, Erasmus University Rotterdam, The Netherlands
3 shared publications Ad F. van Den Heuvel
Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
2 shared publicationsBart J. de Smet
Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
2 shared publications
Latest Publications
- 1 November 2013
- Published by SAGE Publications in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
- Vol. 33 (6) , 708-709
Intraperitoneal Compared with Intravenous Meropenem for Peritoneal Dialysis–Related Peritonitis
- 1 November 2013
- Published by SAGE Publications in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
- Vol. 33 (6) , 708-709
Intraperitoneal Compared with Intravenous Meropenem for Peritoneal Dialysis–Related Peritonitis
- 1 December 2009
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 2 (6) , e6
Response to Letter Regarding Article “Effect of High-Dose Intracoronary Adenosine Administration During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: A Randomized Controlled Trial”
- 1 December 2009
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 2 (6) , e6
Response to Letter Regarding Article “Effect of High-Dose Intracoronary Adenosine Administration During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: A Randomized Controlled Trial”
- 31 August 2009
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 2 (8) , 776-778
Angiographic Restenosis and Clinical Recurrence After Sirolimus- and Paclitaxel-Eluting Stent Implantation
- 31 August 2009
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 2 (8) , 776-778
Angiographic Restenosis and Clinical Recurrence After Sirolimus- and Paclitaxel-Eluting Stent Implantation
- 28 July 2009
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (4)
Response to Letter Regarding Article, “Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review
- 28 July 2009
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (4)
Response to Letter Regarding Article, “Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review
- 18 November 2008
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 72 (7) , 937-942
The feasibility and safety of routine thrombus aspiration in patients with non‐ST‐elevation myocardial infarction
Objectives: To investigate the feasibility and safety of manual thrombus aspiration in patients undergoing percutaneous coronary intervention (PCI) for non‐ST‐elevation myocardial infarction (NSTEMI).Background: Myocardial necrosis in patients with acute coronary syndromes may be a sign of microvascular obstruction, owing to spontaneous or PCI‐induced embolization of atherothrombotic material. Manual thrombus aspiration results in improved myocardial reperfusion in patients undergoing PCI for ST‐elevation myocardial infarction. Currently, no published data on thrombus aspiration in patients with NSTEMI are available.Methods: As part of a prospective cohort study, 70 patients undergoing PCI for NSTEMI were treated with thrombus aspiration (Export Aspiration Catheter, Medtronic, Minneapolis, MN). Histopathological analysis was performed on aspirated material.Results: Thrombus aspiration was effective in 58 patients (83%) and resulted in a marked reduction of TIMI‐thrombus score 4/5 (40% pre‐ versus 7% postthrombus aspiration) and increase of the rate of TIMI‐flow 3 (36% pre‐ versus 66% postthrombus aspiration). The incidence of myocardial blush grade 2 and 3 were 39 and 45%, respectively. Distal embolization was visible in three patients (4%) on the final angiogram.Conclusion: This study demonstrates that thrombus aspiration in most NSTEMI patients is feasible and safe and is associated with a high rate of retrieval of thrombotic material.
- 18 November 2008
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 72 (7) , 937-942
The feasibility and safety of routine thrombus aspiration in patients with non‐ST‐elevation myocardial infarction
Objectives: To investigate the feasibility and safety of manual thrombus aspiration in patients undergoing percutaneous coronary intervention (PCI) for non‐ST‐elevation myocardial infarction (NSTEMI).Background: Myocardial necrosis in patients with acute coronary syndromes may be a sign of microvascular obstruction, owing to spontaneous or PCI‐induced embolization of atherothrombotic material. Manual thrombus aspiration results in improved myocardial reperfusion in patients undergoing PCI for ST‐elevation myocardial infarction. Currently, no published data on thrombus aspiration in patients with NSTEMI are available.Methods: As part of a prospective cohort study, 70 patients undergoing PCI for NSTEMI were treated with thrombus aspiration (Export Aspiration Catheter, Medtronic, Minneapolis, MN). Histopathological analysis was performed on aspirated material.Results: Thrombus aspiration was effective in 58 patients (83%) and resulted in a marked reduction of TIMI‐thrombus score 4/5 (40% pre‐ versus 7% postthrombus aspiration) and increase of the rate of TIMI‐flow 3 (36% pre‐ versus 66% postthrombus aspiration). The incidence of myocardial blush grade 2 and 3 were 39 and 45%, respectively. Distal embolization was visible in three patients (4%) on the final angiogram.Conclusion: This study demonstrates that thrombus aspiration in most NSTEMI patients is feasible and safe and is associated with a high rate of retrieval of thrombotic material.
- 28 October 2008
- Published by Wolters Kluwer Health in Circulation
- Vol. 118 (18) , 1828-1836
Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
Background— The main goal of the initial treatment of ST-segment elevation myocardial infarction is prompt reperfusion of the infarct-related artery. The value of pretreatment with clopidogrel before primary percutaneous coronary intervention is currently unclear. Methods and Results— Studies were retrieved through MEDLINE and Cochrane Controlled Trials Register searches over the past 20 years. Two authors independently performed the study selection and data extraction. Randomized controlled studies were included when the research subjects were unselected patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Pilot trials, studies that enrolled patients undergoing rescue percutaneous coronary intervention, and studies with angiographic assessment not performed by a core laboratory or 2 blinded investigators were excluded. Thirty-eight treatment groups, including 8429 patients, were included. Initial patency was higher in treatment groups in which patients received pretreatment with clopidogrel (34.3%; 95% confidence interval, 32.9 to 35.8) compared with those in which patients did not receive clopidogrel before initial coronary angiography (25.8%; 95% confidence interval, 24.5 to 27.1). In multivariate-weighted logistic regression analysis, pretreatment with clopidogrel was an independent predictor of early reperfusion (odds ratio, 1.51; 95% confidence interval, 1.31 to 1.74; P Conclusions— Initial patency and clinical outcome were improved in treatment groups that received pretreatment with clopidogrel. These results in patients undergoing primary percutaneous coronary intervention are in line with the experience of pretreatment with clopidogrel in elective patients, non–ST-elevation coronary syndromes, and thrombolytic studies.
- 28 October 2008
- Published by Wolters Kluwer Health in Circulation
- Vol. 118 (18) , 1828-1836
Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
Background— The main goal of the initial treatment of ST-segment elevation myocardial infarction is prompt reperfusion of the infarct-related artery. The value of pretreatment with clopidogrel before primary percutaneous coronary intervention is currently unclear. Methods and Results— Studies were retrieved through MEDLINE and Cochrane Controlled Trials Register searches over the past 20 years. Two authors independently performed the study selection and data extraction. Randomized controlled studies were included when the research subjects were unselected patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Pilot trials, studies that enrolled patients undergoing rescue percutaneous coronary intervention, and studies with angiographic assessment not performed by a core laboratory or 2 blinded investigators were excluded. Thirty-eight treatment groups, including 8429 patients, were included. Initial patency was higher in treatment groups in which patients received pretreatment with clopidogrel (34.3%; 95% confidence interval, 32.9 to 35.8) compared with those in which patients did not receive clopidogrel before initial coronary angiography (25.8%; 95% confidence interval, 24.5 to 27.1). In multivariate-weighted logistic regression analysis, pretreatment with clopidogrel was an independent predictor of early reperfusion (odds ratio, 1.51; 95% confidence interval, 1.31 to 1.74; P Conclusions— Initial patency and clinical outcome were improved in treatment groups that received pretreatment with clopidogrel. These results in patients undergoing primary percutaneous coronary intervention are in line with the experience of pretreatment with clopidogrel in elective patients, non–ST-elevation coronary syndromes, and thrombolytic studies.
- 1 September 2008
- Published by Elsevier in The Lancet
- Vol. 372 (9643) , 1034-1035
Thrombus aspiration during percutaneous coronary intervention – Authors' reply
- 1 September 2008
- Published by Elsevier in The Lancet
- Vol. 372 (9643) , 1034-1035
Thrombus aspiration during percutaneous coronary intervention – Authors' reply
- Top Cited Papers
- 1 June 2008
- Published by Elsevier in The Lancet
- Vol. 371 (9628) , 1915-1920
Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study
- 1 June 2008
- Published by Elsevier in The Lancet
- Vol. 371 (9628) , 1915-1920
Top Cited PapersCardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study